Protocol for the development and validation of a risk prediction model for stillbirths from 35 weeks gestation in Australia.
AUROC
Fetal death
Obstetrics
Perinatal
Prediction
Prognostic
Risk
Stillbirth
Journal
Diagnostic and prognostic research
ISSN: 2397-7523
Titre abrégé: Diagn Progn Res
Pays: England
ID NLM: 101718985
Informations de publication
Date de publication:
16 Dec 2020
16 Dec 2020
Historique:
received:
03
03
2020
accepted:
29
10
2020
entrez:
16
12
2020
pubmed:
17
12
2020
medline:
17
12
2020
Statut:
epublish
Résumé
Despite advances in the care of women and their babies in the past century, an estimated 1.7 million babies are born still each year throughout the world. A robust method to estimate a pregnant woman's individualized risk of late-pregnancy stillbirth is needed to inform decision-making around the timing of birth to reduce the risk of stillbirth from 35 weeks of gestation in Australia, a high-resource setting. This is a protocol for a cross-sectional study of all late-pregnancy births in Australia (2005-2015) from 35 weeks of gestation including 5188 stillbirths among 3.1 million births at an estimated rate of 1.7 stillbirths per 1000 births. A multivariable logistic regression model will be developed in line with current Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) guidelines to estimate the gestation-specific probability of stillbirth with prediction intervals. Candidate predictors were identified from systematic reviews and clinical consultation and will be described through univariable regression analysis. To generate a final model, elimination by backward stepwise multivariable logistic regression will be performed. The model will be internally validated using bootstrapping with 1000 repetitions and externally validated using a temporally unique dataset. Overall model performance will be assessed with R A robust method to predict a pregnant woman's individualized risk of late-pregnancy stillbirth is needed to inform timely, appropriate care to reduce stillbirth. Among existing prediction models designed for obstetric use, few have been subject to internal and external validation and many fail to meet recommended reporting standards. In developing a risk prediction model for late-gestation stillbirth with both providers and pregnant women in mind, we endeavor to develop a validated model for clinical use in Australia that meets current reporting standards.
Sections du résumé
BACKGROUND
BACKGROUND
Despite advances in the care of women and their babies in the past century, an estimated 1.7 million babies are born still each year throughout the world. A robust method to estimate a pregnant woman's individualized risk of late-pregnancy stillbirth is needed to inform decision-making around the timing of birth to reduce the risk of stillbirth from 35 weeks of gestation in Australia, a high-resource setting.
METHODS
METHODS
This is a protocol for a cross-sectional study of all late-pregnancy births in Australia (2005-2015) from 35 weeks of gestation including 5188 stillbirths among 3.1 million births at an estimated rate of 1.7 stillbirths per 1000 births. A multivariable logistic regression model will be developed in line with current Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) guidelines to estimate the gestation-specific probability of stillbirth with prediction intervals. Candidate predictors were identified from systematic reviews and clinical consultation and will be described through univariable regression analysis. To generate a final model, elimination by backward stepwise multivariable logistic regression will be performed. The model will be internally validated using bootstrapping with 1000 repetitions and externally validated using a temporally unique dataset. Overall model performance will be assessed with R
DISCUSSION
CONCLUSIONS
A robust method to predict a pregnant woman's individualized risk of late-pregnancy stillbirth is needed to inform timely, appropriate care to reduce stillbirth. Among existing prediction models designed for obstetric use, few have been subject to internal and external validation and many fail to meet recommended reporting standards. In developing a risk prediction model for late-gestation stillbirth with both providers and pregnant women in mind, we endeavor to develop a validated model for clinical use in Australia that meets current reporting standards.
Identifiants
pubmed: 33323131
doi: 10.1186/s41512-020-00089-w
pii: 10.1186/s41512-020-00089-w
pmc: PMC7739473
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Subventions
Organisme : National Health and Medical Research Council
ID : 1116640
Références
BMJ. 2009 Jun 18;338:b2255
pubmed: 19541696
Am J Obstet Gynecol. 2007 Jun;196(6):499-507
pubmed: 17547873
J Clin Epidemiol. 2019 Jun;110:12-22
pubmed: 30763612
Paediatr Perinat Epidemiol. 2018 Nov;32(6):487-494
pubmed: 30346025
Aust N Z J Psychiatry. 2005 Jul;39(7):583-90
pubmed: 15996139
BMC Med Res Methodol. 2014 Mar 19;14:40
pubmed: 24645774
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Med Decis Making. 2001 Jan-Feb;21(1):45-56
pubmed: 11206946
PLoS One. 2017 Mar 7;12(3):e0173461
pubmed: 28267756
Matern Child Health J. 2016 Jun;20(6):1170-7
pubmed: 26679708
Ultrasound Obstet Gynecol. 2016 Nov;48(5):607-612
pubmed: 27561693
J Clin Epidemiol. 2019 Dec;116:137-138
pubmed: 31425736
Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Obstet Gynecol. 2018 Feb;131(2):336-343
pubmed: 29324601
Paediatr Perinat Epidemiol. 2019 Nov;33(6):421-432
pubmed: 31476081
BMJ. 2016 Jun 22;353:i3140
pubmed: 27334381
BMC Pregnancy Childbirth. 2013 Jan 16;13:12
pubmed: 23324309
Surgery. 2016 Jun;159(6):1638-1645
pubmed: 26962006
BMC Med Res Methodol. 2014 Jan 08;14:3
pubmed: 24397587
J Clin Oncol. 2011 Aug 1;29(22):2951-2
pubmed: 21690474
Lancet. 2011 Apr 16;377(9774):1331-40
pubmed: 21496916
Med Decis Making. 2006 Nov-Dec;26(6):565-74
pubmed: 17099194
Semin Fetal Neonatal Med. 2017 Jun;22(3):135-145
pubmed: 28457816
Obstet Gynecol Surv. 2017 Nov;72(11):669-682
pubmed: 29164265
BMC Public Health. 2020 Jan 6;20(1):10
pubmed: 31907008
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
BMJ Paediatr Open. 2019 Mar 15;3(1):e000424
pubmed: 30957032
Am J Obstet Gynecol. 2016 Jan;214(1):79-90.e36
pubmed: 26070707
Eur Heart J. 2014 Aug 1;35(29):1925-31
pubmed: 24898551
Lancet. 2018 Nov 3;392(10158):1639-1646
pubmed: 30269877
Rheum Dis Clin North Am. 2018 May;44(2):327-336
pubmed: 29622299
JAMA Pediatr. 2018 Jul 1;172(7):627-634
pubmed: 29799945
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600
BMJ. 2015 Jun 24;350:h3080
pubmed: 26109551
Med J Aust. 2018 Nov 5;209(9):394-400
pubmed: 30282563
J Matern Fetal Neonatal Med. 2017 Jan;30(1):17-22
pubmed: 26956932
Obstet Gynecol. 2012 Mar;119(3):509-17
pubmed: 22353949
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
BMC Pregnancy Childbirth. 2016 Jul 15;16(1):159
pubmed: 27417076
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Lancet. 2016 Feb 13;387(10019):691-702
pubmed: 26794070
BMC Pregnancy Childbirth. 2016 Sep 20;16:274
pubmed: 27649795